Medharbor Pharma Private Limited
About Medharbor Pharma Private Limited
Data last updated:
Medharbor Pharma Private Limited is a private limited company based in Chandigarh, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 31 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24299CH2019PTC042852. Its GSTIN is 04AANCM2055R1ZZ (Chandigarh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Kavita Goyal and Mukesh Guleria.
Its last annual general meeting (AGM) was held on 26 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 157/A Shop No 8 First Floor Sarangpur Near Pgi Chandigarh, Chandigarh, India – 160014.
As per the financials filed for FY 2025, the company reported a revenue of ₹67.16 Lakh, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹3.55 Lakh (net margin 5.3%) and EBITDA of ₹5.17 Lakh (EBITDA margin 7.7%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years.
Company details
Contact details
Medharbor Pharma Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No 157/A Shop No 8 First Floor Sarangpur Near Pgi Chandigarh, Chandigarh, India – 160014
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
To see the full contact details of Medharbor Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medharbor Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medharbor Pharma Private Limited, buy the company report.
Financials of Medharbor Pharma Private Limited
FY 2025 filings availableMedharbor Pharma Private Limited reported revenue of ₹67.16 Lakh (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over three years, including 20% growth in the latest year. EBITDA rose 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.55 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.7% | ||||
| Net Profit Margin | 5.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medharbor Pharma Private Limited, buy the company report.
Board of directors of Medharbor Pharma Private Limited
Medharbor Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kavita Goyal | Director | 31 Dec 2019 | 6 Years 9 Months | Current |
| Mukesh Guleria | Director | 01 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Medharbor Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rayan Footwear Private Limited | ₹67.17 Lakh (FY 2021) | -8.0% | Malappuram, Kerala, India | |||
| Kalash Metals Private Limited | ₹67.17 Lakh (FY 2025) | -9.0% | Mumbai, Maharashtra, India | |||
| Rajat Grain and Foods Private Limited | ₹67.17 Lakh (FY 2023) | -67.0% | Raigarh, Chhattisgarh, India | |||
| Jigson Pharmaceuticals Private Limited | ₹67.17 Lakh (FY 2025) | 4.0% | Ahmedabad, Gujarat, India | |||
| Agrosia Adzuvant Private Limited | ₹67.16 Lakh (FY 2020) | -7.0% | Maharashtra, India | |||
| Medharbor Pharma Private Limitedthis company | ₹67.16 Lakh (FY 2025) | ₹3.55 Lakh | 5.3% | 20.0% | Chandigarh, India | |
| Perfect Integrity Management Solutions Private Limited | ₹67.15 Lakh (FY 2025) | -10.0% | Delhi, India | |||
| Muscle Masters Endeavor Private Limited | ₹67.14 Lakh (FY 2021) | 1483.0% | New Delhi, Delhi, India | |||
| Invention Estate Ventures Private Limited | ₹67.13 Lakh (FY 2016) | 3986181.0% | Kolkata, West Bengal, India | |||
| Matina Enterprises Private Limited | ₹67.13 Lakh (FY 2016) | -40.0% | New Delhi, Delhi, India | |||
| Touchwin Projects Private Limited | ₹67.13 Lakh (FY 2025) | 212.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Medharbor Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medharbor Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medharbor Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medharbor Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AANCM2055R1ZZ | Chandigarh | Active | 19 Mar 2020 |
To see the full GST registrations and return filing status of Medharbor Pharma Private Limited, buy the company report.
Recent activity
Medharbor Pharma Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Mukesh Guleria ceased to be Additional Director on 30 Dec 2020.
Frequently asked questions
Medharbor Pharma is an active private limited company based in Chandigarh, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 31 December 2019 (7+ years old) and is registered under CIN U24299CH2019PTC042852.
Medharbor Pharma has 2 current directors:
- Kavita Goyal - Director
- Mukesh Guleria - Director
The latest financial statements of Medharbor Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 August 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Medharbor Pharma is 04AANCM2055R1ZZ, registered in Chandigarh.
The CIN (Corporate Identification Number) of Medharbor Pharma is U24299CH2019PTC042852. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medharbor Pharma was incorporated on 31 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Medharbor Pharma by revenue are Rayan Footwear Private Limited, Kalash Metals Private Limited, Rajat Grain and Foods Private Limited, Jigson Pharmaceuticals Private Limited, Agrosia Adzuvant Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Mukesh Guleria ceased to be Additional Director on 30 Dec 2020. Manish Kumar ceased to be Director on 01 Sep 2020. Mukesh Guleria was appointed as Director on 01 Sep 2020. Medharbor Pharma has 5 board changes on record in total.
The registered office of Medharbor Pharma is at Plot No 157A Shop No 8 First Floor Sarangpur Near Pgi Chandigarh, Chandigarh, India – 160014.
Medharbor Pharma operates in the chemicals industry, in the fine chemicals and other chemical products segment.
Medharbor Pharma can be reached at its registered office: Plot No 157A Shop No 8 First Floor Sarangpur Near Pgi Chandigarh, Chandigarh, India – 160014.